Tropical Spastic Paraparesis Global Clinical Trials Review, H2, 2014

NEW YORK, Aug. 25, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Tropical Spastic Paraparesis Global Clinical Trials Review, H2, 2014

http://www.reportlinker.com/p02312350/Tropical-Spastic-Paraparesis-Global-Clinical-Trials-Review-H2-2014.html

Tropical Spastic Paraparesis Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, "Tropical Spastic Paraparesis Global Clinical Trials Review, H2, 2014" provides data on the Tropical Spastic Paraparesis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Tropical Spastic Paraparesis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Tropical Spastic Paraparesis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Tropical Spastic Paraparesis 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Central and South America 12
Clinical Trials by G7 Countries: Proportion of Tropical Spastic Paraparesis to Central Nervous System Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Tropical Spastic Paraparesis to Central Nervous System Clinical Trials 16
Clinical Trials in E7 Countries by Trial Status 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Clinical Trials by End Point Status 21
Unaccomplished Trials of Tropical Spastic Paraparesis 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Drugs 25
Clinical Trial Overview of Top Institutes / Government 26
National Institute of Neurological Disorders and Stroke 26
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 26
Imperial College London 27
Clinical Trial Overview of Imperial College London 27
Hospital Universitrio Professor Edgard Santos 28
Clinical Trial Overview of Hospital Universitrio Professor Edgard Santos 28
St. Marianna University School of Medicine 29
Clinical Trial Overview of St. Marianna University School of Medicine 29
University of Sao Paulo 30
Clinical Trial Overview of University of Sao Paulo 30
National Taiwan University Hospital 31
Clinical Trial Overview of National Taiwan University Hospital 31
University of Oxford 32
Clinical Trial Overview of University of Oxford 32
National Cancer Institute 33
Clinical Trial Overview of National Cancer Institute 33
Massachusetts General Hospital 34
Clinical Trial Overview of Massachusetts General Hospital 34
Five Key Clinical Profiles 35
Appendix 49
Abbreviations 49
Definitions 49
Research Methodology 50
Secondary Research 50
About GlobalData 51
Contact Us 51
Disclaimer 51
Source 51

List of Tables
Tropical Spastic Paraparesis Therapeutics, Global, Clinical Trials by Region, 2014* 6
Tropical Spastic Paraparesis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Tropical Spastic Paraparesis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Tropical Spastic Paraparesis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Tropical Spastic Paraparesis Therapeutics Clinical Trials, Europe, Top Countries, 2014* 10
Tropical Spastic Paraparesis Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Tropical Spastic Paraparesis Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 12
Proportion of Tropical Spastic Paraparesis to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 13
Tropical Spastic Paraparesis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Tropical Spastic Paraparesis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Tropical Spastic Paraparesis to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 16
Tropical Spastic Paraparesis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 17
Tropical Spastic Paraparesis Therapeutics, Global, Clinical Trials by Phase, 2014* 18
Tropical Spastic Paraparesis Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 19
Tropical Spastic Paraparesis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 20
Tropical Spastic Paraparesis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 21
Tropical Spastic Paraparesis Therapeutics, Global, Terminated Clinical Trials, 2014* 22
Tropical Spastic Paraparesis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Tropical Spastic Paraparesis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 24
Tropical Spastic Paraparesis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 25
Tropical Spastic Paraparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2014* 26
Tropical Spastic Paraparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Imperial College London, 2014* 27
Tropical Spastic Paraparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Universitrio Professor Edgard Santos, 2014* 28
Tropical Spastic Paraparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Marianna University School of Medicine, 2014* 29
Tropical Spastic Paraparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Sao Paulo, 2014* 30
Tropical Spastic Paraparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2014* 31
Tropical Spastic Paraparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2014* 32
Tropical Spastic Paraparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 33
Tropical Spastic Paraparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014* 34

List of Figures
Tropical Spastic Paraparesis Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Tropical Spastic Paraparesis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Tropical Spastic Paraparesis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Tropical Spastic Paraparesis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 9
Tropical Spastic Paraparesis Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 11
Tropical Spastic Paraparesis Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 12
Proportion of Tropical Spastic Paraparesis to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 13
Tropical Spastic Paraparesis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Tropical Spastic Paraparesis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Tropical Spastic Paraparesis to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 16
Tropical Spastic Paraparesis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 17
Tropical Spastic Paraparesis Therapeutics, Global, Clinical Trials by Phase (%), 2014* 18
Tropical Spastic Paraparesis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 19
Tropical Spastic Paraparesis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 20
Tropical Spastic Paraparesis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Tropical Spastic Paraparesis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 24
Tropical Spastic Paraparesis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 25
GlobalData Methodology 50


To order this report: Tropical Spastic Paraparesis Global Clinical Trials Review, H2, 2014
http://www.reportlinker.com/p02312350/Tropical-Spastic-Paraparesis-Global-Clinical-Trials-Review-H2-2014.html



__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker